Lidocaină Grindeks

Lidocaine, the active ingredient in Lidocaină Grindeks, is a local anesthetic presented as a sterile solution for epidural, intramuscular and intravenous use. It provides rapid, reversible loss of sensation for minor surgical procedures, epidural analgesia and peripheral nerve blocks.

GNH USA supplies Lidocaină Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaină Grindeks is a local anesthetic used to block nerve conduction in various clinical settings.

- Minor surgical procedures: provides rapid onset of numbness to facilitate painless incision and manipulation. - Epidural analgesia: delivers analgesic effect for labor or postoperative pain control. - Nerve block: produces targeted anesthesia of specific peripheral nerves for diagnostic or therapeutic purposes.

Lidocaină Grindeks may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Transient burning or tingling at the injection site. - Mild hypotension. - Dizziness. - Nausea.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Cardiac arrhythmia. - Central nervous system toxicity such as seizures or loss of consciousness. - Methemoglobinemia.

When using Lidocaină Grindeks, clinicians should observe several safety measures.

- Assess patient allergy history: confirm no known lidocaine hypersensitivity. - Monitor cardiovascular status: observe blood pressure and heart rate during administration. - Use lowest effective dose: titrate to achieve desired anesthesia. - Avoid in patients with severe hepatic impairment: adjust dosing accordingly. - Store at ambient temperature: keep in original container, protect from light and moisture.

Lidocaină Grindeks can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may cause additive cardiotoxicity. - Beta‑blockers (e.g., propranolol): increase risk of severe bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may raise lidocaine plasma levels. - General anesthetics (e.g., propofol): may potentiate central nervous system depression. - Diuretics (e.g., furosemide): may enhance lidocaine toxicity.